Listed

Palvella Therapeutics, Inc.

PVLANasdaqCIK 1583648HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q3 FY2024
Operating income−$21.4m, Q2 FY2026
Net income−$21.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m19.5Revenue, Q3 FY2023, three months to 2023-09-30$19.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-13, accession 0001437749-24-034891.Report this figure1.3Revenue, Q4 FY2023, three months to 2023-12-31$1.3m. XBRL concept us-gaap:Revenues. 10-K filed 2024-03-29, accession 0001437749-24-010123. Derived: 12-month figure less the 9-month figure.Report this figure0.1Revenue, Q1 FY2024, three months to 2024-03-31$53.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2024-05-15, accession 0001437749-24-017037.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-08-14, accession 0001437749-24-026778.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-13, accession 0001437749-24-034891.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m9.6Research and development, Q3 FY2023, three months to 2023-09-30$9.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2023-11-14, accession 0001437749-23-031957.Report this figure(28.6)Research and development, Q4 FY2023, three months to 2023-12-31−$28.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0000950170-25-047212. Derived: 12-month figure less the 9-month figure.Report this figure1.0Research and development, Q1 FY2024, three months to 2024-03-31$984.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0000950170-25-071998.Report this figure1.4Research and development, Q2 FY2024, three months to 2024-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108438.Report this figure3.2Research and development, Q3 FY2024, three months to 2024-09-30$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure2.5Research and development, Q4 FY2024, three months to 2024-12-31$2.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-133372. Derived: 12-month figure less the 9-month figure.Report this figure4.1Research and development, Q1 FY2025, three months to 2025-03-31$4.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure5.1Research and development, Q2 FY2025, three months to 2025-06-30$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure6.5Research and development, Q3 FY2025, three months to 2025-09-30$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure7.1Research and development, Q4 FY2025, three months to 2025-12-31$7.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-133372. Derived: 12-month figure less the 9-month figure.Report this figure9.3Research and development, Q1 FY2026, three months to 2026-03-31$9.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure12.5Research and development, Q2 FY2026, three months to 2026-06-30$12.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure
Operating income$m(11.8)Operating income, Q3 FY2023, three months to 2023-09-30−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001437749-24-034891.Report this figure13.4Operating income, Q4 FY2023, three months to 2023-12-31$13.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047212. Derived: 12-month figure less the 9-month figure.Report this figure(1.8)Operating income, Q1 FY2024, three months to 2024-03-31−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0000950170-25-071998.Report this figure(2.9)Operating income, Q2 FY2024, three months to 2024-06-30−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108438.Report this figure(5.1)Operating income, Q3 FY2024, three months to 2024-09-30−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure(4.4)Operating income, Q4 FY2024, three months to 2024-12-31−$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-133372. Derived: 12-month figure less the 9-month figure.Report this figure(7.9)Operating income, Q1 FY2025, three months to 2025-03-31−$7.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure(9.3)Operating income, Q2 FY2025, three months to 2025-06-30−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure(10.2)Operating income, Q3 FY2025, three months to 2025-09-30−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure(11.3)Operating income, Q4 FY2025, three months to 2025-12-31−$11.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-133372. Derived: 12-month figure less the 9-month figure.Report this figure(14.9)Operating income, Q1 FY2026, three months to 2026-03-31−$14.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure(21.4)Operating income, Q2 FY2026, three months to 2026-06-30−$21.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$mnot reportednot reported0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0000950170-25-071998.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0000950170-25-108438.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-31, accession 0001193125-26-133372. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-31, accession 0001193125-26-133372. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure
Net income$m(10.8)Net income, Q3 FY2023, three months to 2023-09-30−$10.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001437749-24-034891.Report this figure38.7Net income, Q4 FY2023, three months to 2023-12-31$38.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047212. Derived: 12-month figure less the 9-month figure.Report this figure(2.5)Net income, Q1 FY2024, three months to 2024-03-31−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure(4.2)Net income, Q2 FY2024, three months to 2024-06-30−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure(6.8)Net income, Q3 FY2024, three months to 2024-09-30−$6.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure(4.0)Net income, Q4 FY2024, three months to 2024-12-31−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-133372. Derived: 12-month figure less the 9-month figure.Report this figure(8.2)Net income, Q1 FY2025, three months to 2025-03-31−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure(9.5)Net income, Q2 FY2025, three months to 2025-06-30−$9.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure(11.3)Net income, Q3 FY2025, three months to 2025-09-30−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure(12.7)Net income, Q4 FY2025, three months to 2025-12-31−$12.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-133372. Derived: 12-month figure less the 9-month figure.Report this figure(15.8)Net income, Q1 FY2026, three months to 2026-03-31−$15.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure(21.9)Net income, Q2 FY2026, three months to 2026-06-30−$21.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure
Diluted EPS$ per share(8.70)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$8.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001437749-24-034891.Report this figurenot reported(1.54)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0000950170-25-071998.Report this figure(2.47)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$2.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108438.Report this figure(3.94)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$3.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figurenot reported(0.74)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure(0.86)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure(1.03)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figurenot reported(1.20)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure(1.52)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure
Basic EPS$ per share(8.70)Basic EPS, Q3 FY2023, three months to 2023-09-30−$8.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001437749-24-034891.Report this figurenot reported(1.54)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0000950170-25-071998.Report this figure(2.47)Basic EPS, Q2 FY2024, three months to 2024-06-30−$2.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-108438.Report this figure(3.94)Basic EPS, Q3 FY2024, three months to 2024-09-30−$3.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figurenot reported(0.74)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure(0.86)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.86 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure(1.03)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figurenot reported(1.20)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure(1.52)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure

Balance sheet

Cash and equivalents$187.8m, Q2 FY2026
Shareholders' equity$216.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m32.9Cash and equivalents, Q3 FY2023, at 2023-09-30$32.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001437749-23-031957.Report this figure7.4Cash and equivalents, FY2023, at 2023-12-31$7.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0000950170-25-047212.Report this figure19.1Cash and equivalents, Q1 FY2024, at 2024-03-31$19.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001437749-24-017037.Report this figure19.7Cash and equivalents, Q2 FY2024, at 2024-06-30$19.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001437749-24-026778.Report this figure19.4Cash and equivalents, Q3 FY2024, at 2024-09-30$19.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001437749-24-034891.Report this figure83.6Cash and equivalents, FY2024, at 2024-12-31$83.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001193125-26-133372.Report this figure75.6Cash and equivalents, Q1 FY2025, at 2025-03-31$75.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0000950170-25-071998.Report this figure70.4Cash and equivalents, Q2 FY2025, at 2025-06-30$70.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0000950170-25-108438.Report this figure63.6Cash and equivalents, Q3 FY2025, at 2025-09-30$63.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure58.0Cash and equivalents, FY2025, at 2025-12-31$58.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure206Cash and equivalents, Q1 FY2026, at 2026-03-31$206.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure188Cash and equivalents, Q2 FY2026, at 2026-06-30$187.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure
Current assets$m59.1Current assets, Q3 FY2023, at 2023-09-30$59.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001437749-23-031957.Report this figure7.5Current assets, FY2023, at 2023-12-31$7.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047212.Report this figurenot reportednot reportednot reported88.2Current assets, FY2024, at 2024-12-31$88.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001193125-26-133372.Report this figure79.4Current assets, Q1 FY2025, at 2025-03-31$79.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-071998.Report this figure73.7Current assets, Q2 FY2025, at 2025-06-30$73.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108438.Report this figure66.9Current assets, Q3 FY2025, at 2025-09-30$66.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure59.0Current assets, FY2025, at 2025-12-31$59.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure263Current assets, Q1 FY2026, at 2026-03-31$263.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure253Current assets, Q2 FY2026, at 2026-06-30$253.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure
Total assets$m59.4Total assets, Q3 FY2023, at 2023-09-30$59.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001437749-23-031957.Report this figure7.5Total assets, FY2023, at 2023-12-31$7.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0000950170-25-047212.Report this figure29.5Total assets, Q1 FY2024, at 2024-03-31$29.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001437749-24-017037.Report this figure25.1Total assets, Q2 FY2024, at 2024-06-30$25.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001437749-24-026778.Report this figure20.5Total assets, Q3 FY2024, at 2024-09-30$20.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001437749-24-034891.Report this figure88.2Total assets, FY2024, at 2024-12-31$88.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001193125-26-133372.Report this figure79.4Total assets, Q1 FY2025, at 2025-03-31$79.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0000950170-25-071998.Report this figure73.7Total assets, Q2 FY2025, at 2025-06-30$73.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-108438.Report this figure66.9Total assets, Q3 FY2025, at 2025-09-30$66.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure59.6Total assets, FY2025, at 2025-12-31$59.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure264Total assets, Q1 FY2026, at 2026-03-31$263.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure254Total assets, Q2 FY2026, at 2026-06-30$253.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure
Current liabilities$m28.9Current liabilities, Q3 FY2023, at 2023-09-30$28.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001437749-23-031957.Report this figure2.4Current liabilities, FY2023, at 2023-12-31$2.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047212.Report this figure7.5Current liabilities, Q1 FY2024, at 2024-03-31$7.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001437749-24-017037.Report this figure6.3Current liabilities, Q2 FY2024, at 2024-06-30$6.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001437749-24-026778.Report this figure4.3Current liabilities, Q3 FY2024, at 2024-09-30$4.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001437749-24-034891.Report this figure12.0Current liabilities, FY2024, at 2024-12-31$12.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001193125-26-133372.Report this figure9.0Current liabilities, Q1 FY2025, at 2025-03-31$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-071998.Report this figure9.6Current liabilities, Q2 FY2025, at 2025-06-30$9.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108438.Report this figure10.3Current liabilities, Q3 FY2025, at 2025-09-30$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure11.3Current liabilities, FY2025, at 2025-12-31$11.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure9.1Current liabilities, Q1 FY2026, at 2026-03-31$9.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure11.9Current liabilities, Q2 FY2026, at 2026-06-30$11.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure
Total liabilities$m28.9Total liabilities, Q3 FY2023, at 2023-09-30$28.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001437749-23-031957.Report this figure11.4Total liabilities, FY2023, at 2023-12-31$11.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0000950170-25-047212.Report this figurenot reportednot reportednot reported25.6Total liabilities, FY2024, at 2024-12-31$25.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001193125-26-133372.Report this figure23.9Total liabilities, Q1 FY2025, at 2025-03-31$23.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0000950170-25-071998.Report this figure26.0Total liabilities, Q2 FY2025, at 2025-06-30$26.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0000950170-25-108438.Report this figure28.3Total liabilities, Q3 FY2025, at 2025-09-30$28.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure31.6Total liabilities, FY2025, at 2025-12-31$31.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure31.4Total liabilities, Q1 FY2026, at 2026-03-31$31.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure36.6Total liabilities, Q2 FY2026, at 2026-06-30$36.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure
Shareholders' equity$m30.5Shareholders' equity, Q3 FY2023, at 2023-09-30$30.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001437749-24-034891.Report this figure(74.5)Shareholders' equity, FY2023, at 2023-12-31−$74.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001193125-26-133372.Report this figure(76.9)Shareholders' equity, Q1 FY2024, at 2024-03-31−$76.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure(80.8)Shareholders' equity, Q2 FY2024, at 2024-06-30−$80.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure(87.4)Shareholders' equity, Q3 FY2024, at 2024-09-30−$87.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure62.6Shareholders' equity, FY2024, at 2024-12-31$62.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure55.6Shareholders' equity, Q1 FY2025, at 2025-03-31$55.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure47.8Shareholders' equity, Q2 FY2025, at 2025-06-30$47.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure38.7Shareholders' equity, Q3 FY2025, at 2025-09-30$38.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure28.0Shareholders' equity, FY2025, at 2025-12-31$28.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure232Shareholders' equity, Q1 FY2026, at 2026-03-31$232.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure217Shareholders' equity, Q2 FY2026, at 2026-06-30$216.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure

Cash flow

Operating cash flow−$12.8m, Q2 FY2026
Capital expenditure$0, Q3 FY2024
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(9.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$9.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001437749-24-034891. Derived: 9-month figure less the 6-month figure.Report this figure20.4Operating cash flow, Q4 FY2023, three months to 2023-12-31$20.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0000950170-25-047212. Derived: 12-month figure less the 9-month figure.Report this figure(1.1)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0000950170-25-071998.Report this figure(1.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-108438. Derived: 6-month figure less the 3-month figure.Report this figure(2.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-276119. Derived: 9-month figure less the 6-month figure.Report this figure(5.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-133372. Derived: 12-month figure less the 9-month figure.Report this figure(6.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure(5.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-331574. Derived: 6-month figure less the 3-month figure.Report this figure(7.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$7.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-276119. Derived: 9-month figure less the 6-month figure.Report this figure(4.9)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-133372. Derived: 12-month figure less the 9-month figure.Report this figure(10.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$10.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure(12.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$12.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-331574. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$69.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001437749-24-034891. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Capital expenditure, Q4 FY2023, three months to 2023-12-31−$13.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-29, accession 0001437749-24-010123. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-05-15, accession 0001437749-24-017037.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-08-14, accession 0001437749-24-026778. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001437749-24-034891. Derived: 9-month figure less the 6-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)14.36m, Q2 FY2026
Line itemUnitQ1 FY20222022-03-31Q2 FY20222022-06-30Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares73.7Diluted shares (weighted), Q1 FY2022, three months to 2022-03-3173,711,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-05-11, accession 0001583648-22-000025.Report this figure74.1Diluted shares (weighted), Q2 FY2022, three months to 2022-06-3074,125,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-10, accession 0001437749-23-023085.Report this figure1.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-301,098,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001437749-24-026778.Report this figure1.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-301,236,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001437749-24-034891.Report this figure1.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-311,770,167 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0000950170-25-071998.Report this figure1.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-301,770,167 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-108438.Report this figure1.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,770,167 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure11.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3111,013,697 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure11.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3011,052,741 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure11.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3011,064,282 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-276119.Report this figure13.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3113,085,271 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210463.Report this figure14.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3014,356,219 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure

Shares outstanding: 14.41mShares outstanding, period not labelled, at 2026-07-3114,408,407 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-331574.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. Listed shows no prices and gives no investment advice.